Georgios Varsos is a versatile professional in the healthcare and life sciences industry with interdisciplinary expertise in business development, venture capital investing, management consulting, and scientific research. With nine years of experience, Georgios' passion lies in advancing medical innovations to enhance the accuracy, safety, and effectiveness of radiotherapy interventions for brain tumor patients. He is the Director of US Business Development at RTsafe, a medical technology company, and also serves as a Venture Partner at VU Venture Partners, where he sources healthcare investment opportunities.

Georgios has a Ph.D. in Clinical Neurosciences from the University of Cambridge, where his scientific work resulted in the elimination of a significant 60-year drawback of a method for assessing brain hemodynamics. He has 37 scientific publications and 920+ citations, and his research set the basis for a $170K+ NIH research grant. Before joining RTsafe, Georgios worked for five years in strategy and management consulting, where he led projects of ~$1M in total value, managing cross-functional teams of consultants, programmers, and MDs. His work in Health Economics and Outcomes Research (HEOR) generated real-world data evidence for clinical-stage biopharma clients.

Georgios is a certified PMP project manager who is passionate about supporting entrepreneurship and professional development. He serves as a start-up judge, mentor, and career coach at leading accelerators and business schools globally, including MassChallenge, MIT Enterprise Forum, MedTech Innovator, University of Cambridge, Imperial College London, and Northeastern University. With 15 awards and scholarships for scientific, entrepreneurship, and philanthropy achievements, Georgios is a leader in the healthcare and life sciences industry.